C07C 403/04
Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a
Official title: having side-chains substituted by halogen atoms
C07C403/04 (Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a) appears on 25 US grants and 14 published applications in this corpus.
Search patents in C07C- Granted patents
- 25
- Published applications
- 14
- Assignees
- 14
- Inventors
- 55
- Latest grant
- 14 Jan 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 3 | 0 |
| 1979 | 1 | 0 |
| 1980 | 1 | 0 |
| 1981 | 1 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 3 | 0 |
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 1 |
| 2003 | 1 | 0 |
| 2004 | 0 | 2 |
| 2005 | 0 | 1 |
| 2006 | 1 | 0 |
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 1 | 0 |
| 2016 | 1 | 1 |
| 2017 | 0 | 0 |
| 2018 | 1 | 0 |
| 2019 | 0 | 2 |
| 2020 | 1 | 1 |
| 2021 | 2 | 1 |
| 2022 | 1 | 1 |
| 2023 | 1 | 2 |
| 2024 | 0 | 0 |
| 2025 | 1 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Triazole n-linked carbamoyl cyclohexyl acids as LPA antagonists14 Jan 2025US 12,195,444 B2Bristol-Myers Squibb Company
- Triazole N-linked carbamoyl cyclohexyl acids as LPA antagonists11 Jul 2023US 11,697,646 B2Bristol-Myers Squibb Company
- Methods and compositions for treating atopic dermatitis21 Jun 2022US 11,364,209 B2Golden Biotechnology Corporation
- Process for preparing chiral 2,3-dihydrothiazolo[3,2-A] pyrimidin-4-ium compounds15 Jun 2021US 11,034,703 B2BASF SE
- Triazole n-linked carbamoyl cyclohexyl acids as LPA antagonists18 May 2021US 11,008,300 B2Bristol-Myers Squibb Company
- Triazole N-Linked Carbamoyl Cyclohexyl Acids as LPA Antagonists26 Oct 2023US 2023/0339884 A1Bristol-Myers Squibb Company
- Vaccine adjuvants and methods of synthesizing and using the same12 Oct 2023US 2023/0321228 A1Amyris, Inc.
- Triazole n-linked carbamoyl cyclohexyl acids as lpa antagonists13 Oct 2022US 2022/0324829 A1Bristol-Myers Squibb Company
- Process for preparing chiral 2,3-dihydrothiazolo[3,2-a]pyrimidin-4-ium compounds25 Mar 2021US 2021/0087207 A1BASF SE
- Triazole n-linked carbamoyl cyclohexyl acids as lpa antagonists14 May 2020US 2020/0148665 A1Bristol-Myers Squibb Company
Most cited
By later US patents
- Triazole N-linked carbamoyl cyclohexyl acids as LPA antagonists26US 10,662,172 B2Bristol-Myers Squibb Company · 2020
- Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers19US 9,278,085 B2Edison Pharmaceuticals, Inc. · 2016
- Preparation of astaxanthin novel intermediates therefor and the preparation thereof15US 5,455,362 ABASF SE · 1995
- 1-(2,6,6 -Trimethyl-3-hydroxy-1-cyclohexen-1-yl)-3-methyl-penta-1,4-diene[or 1-yn-4-EN]-3-ols9US 4,098,827 AHoffmann-La Roche Inc. · 1978
- Hydroxy-acetylene-substituted cyclohexenone7US 4,000,198 AHoffmann-La Roche Inc. · 1976